NCT00329017

Brief Summary

A study to examine the potential associations between common single nucleotide polymorphisms and pre-cancerous conditions in breast tissue specimens from postmenopausal women.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2005

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2005

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

May 19, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 24, 2006

Completed
9.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2015

Completed
Last Updated

October 10, 2019

Status Verified

October 1, 2019

Enrollment Period

10.5 years

First QC Date

May 19, 2006

Last Update Submit

October 7, 2019

Conditions

Keywords

SNPssingle nucleotide polymorphismbreast atypiabreast epithelial hyperplasiahigh risk for breast cancer

Outcome Measures

Primary Outcomes (1)

  • Correlation of SNP patterns with cytlomorphology of breast fine needle aspirates.

    develoment of algorithm for prediction of risk of developing breast cancer.

    ongoing

Study Arms (1)

1

Post-menopausal women who are at increased risk for development of breast cancer on the basis of family or personal history.

Procedure: Fine needle aspiration

Interventions

Fine needle aspiration

1

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Post menopausal women, on or off hormone replacement therapy, at high risk of developing breast cancer

You may qualify if:

  • postmenopausal women on or off hormone replacement therapy
  • at high risk of developing breast cancer determined by family or personal history
  • postmenopausal women not on hormone replacement therapy for at minimum six months prior to corresponding aspiration
  • willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies

You may not qualify if:

  • women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Fine needle aspirate

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Biopsy, Fine-Needle

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Biopsy, NeedleBiopsyCytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingDiagnostic Techniques, SurgicalSurgical Procedures, OperativePuncturesInvestigative Techniques

Study Officials

  • Carol J Fabian, MD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor, Director Breast Cancer Prevention Unit

Study Record Dates

First Submitted

May 19, 2006

First Posted

May 24, 2006

Study Start

May 1, 2005

Primary Completion

November 12, 2015

Study Completion

November 12, 2015

Last Updated

October 10, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Global results will be published.

Locations